Last reviewed · How we verify

NCT07309627

VR Therapy Effects in Lumbar Disc Herniation

Completed NA Last updated 13 April 2026
What this trial tests

NA trial testing Conventional Physiotherapy in Lumbar Disc Herniation in 93 participants. Completed in 31 December 2023.

Timeline
1 November 2023
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorUskudar University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment93
Start date1 November 2023
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Uskudar University

Who can join

Adults 18 to 65, any sex, with Lumbar Disc Herniation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effects of incorporating virtual reality (VR) therapy into routine physical therapy (RPT) on balance, pain, kinesiophobia, quality of life, and depression in individuals diagnosed with lumbar disc herniation (LDH).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Conventional Physiotherapy

Trials testing the same drug.

Other recruiting trials for Lumbar Disc Herniation

Currently open trials in the same condition.

Other Uskudar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07309627.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing